세계의 통증 패치 시장 규모 조사 및 예측: 제품 유형(비오피오이드, 오피오이드 패치), 유형(처방약, OTC 의약품), 유통 채널(병원 약국, 약국 및 소매 약국, 기타) 및 지역별 분석(2023-2030년)

Global Pain Patch Market is valued approximately USD 5.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.30% over the forecast period 2023-2030. A pain patch, also known as a transdermal patch, is a medicated adhesive patch that is applied to the skin to provide long-lasting pain relief. The patch contains a medication that is gradually released into the bloodstream through the skin, providing a steady and continuous dose of pain medication over a period of several hours or days. Pain patches are commonly used to manage chronic pain, such as pain from arthritis, back pain, or nerve damage. They can also be used to manage acute pain, such as pain after surgery or an injury. The Pain Patch market is expanding because of factors such as increasing prevalence of Arthritis, increase in the number of accident cases globally and increasing prevelance of chronic disorders.

According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus, rising prevalence of arthritis is propelling the market growth. Furthermore, chronic pain-producing illnesses such joint problems, neuropathic pain, cancer, and others are more common in older populations. Thus, an increase in chronic pain cases may be a market growth driver. For instance, according to a National Library of Medicine 2021 article, the number of Americans with diabetic neuropathy increased from 30 million in 2019 to 85 million in 2021, which is what is driving the expansion of the pain patch industry. In addition, growing technological advances in medical technology and increase in incidence of sports and work -related trauma injuries is creating lucrative opportunity to the market. However, limited indications and several regulatory Issues stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pain Patch Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing chronic disease prevalence along with rising cases of arthritis in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of sports related injuries, geographic expansion of key players.

Major market players included in this report are:

• NEXGEL Advanced Hydrogel Solutions
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co.,Inc.
• Endo International plc.
• Purdue Pharma L.P.
• Amneal Pharmaceuticals LLC
• Grunenthal

Recent Developments in the Market:

• In August 2020, The U.S. Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals, Inc., a pharmaceutical manufacturer, for an abbreviated new drug application (ANDA) for a generic version of Lidocaine Patch, 5%. The generic version of Lidoderm Patch, 5% is called Lidocaine Patch, 5%, and it is used to treat post-herpetic neuralgia.
• In January 2021, Hisamitsu Pharmaceutical Co., Inc. announces that a new formulation of transdermal analgesic anti-inflammatory patches called "Mohrus Paps XR 120 mg and 240 mg" has been approved for a partial change of the approved matters. This was done to lessen the irritation that the presently employed additives created.

Global Pain Patch Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product Type, Type, Distribution Channel, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
• The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

• Non-Opioid Patches
• Opioid Patches

By Type:

• Prescription Medicines
• OTC Medicines

By Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

By Region:

• North America
  • U.S.
  • Canada

• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE

• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC

• Latin America
  • Brazil
  • Mexico

• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Pain Patch Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Pain Patch Market, by Product Type, 2020-2030 (USD Billion)
  • 1.2.3. Pain Patch Market, by Type, 2020-2030 (USD Billion)
  • 1.2.4. Pain Patch Market, by Distribution Channel, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Pain Patch Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Pain Patch Market Dynamics

• 3.1. Pain Patch Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of Arthritis
    • 3.1.1.2. Increase in the number of accident cases globally.
    • 3.1.1.3. Increasing prevelance of chronic disorders
  • 3.1.2. Market Challenges
    • 3.1.2.1. Limited indications
    • 3.1.2.2. Regulatory Issues
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing technological advances in medical technology
    • 3.1.3.2. increase in incidence of sports and work-related trauma injuries

Chapter 4. Global Pain Patch Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Pain Patch Market, by Product Type

• 5.1. Market Snapshot
• 5.2. Global Pain Patch Market by Product Type, Performance - Potential Analysis
• 5.3. Global Pain Patch Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
• 5.4. Pain Patch Market, Sub Segment Analysis
  • 5.4.1. Non-Opioid Patches
  • 5.4.2. Opioid Patches

Chapter 6. Global Pain Patch Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Pain Patch Market by Type, Performance - Potential Analysis
• 6.3. Global Pain Patch Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 6.4. Pain Patch Market, Sub Segment Analysis
  • 6.4.1. Prescription Medicines
  • 6.4.2. OTC Medicines

Chapter 7. Global Pain Patch Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Pain Patch Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Pain Patch Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
• 7.4. Pain Patch Market, Sub Segment Analysis
  • 7.4.1. Hospital Pharmacies
  • 7.4.2. Drug Stores and Retail Pharmacies
  • 7.4.3. Online Providers

Chapter 8. Global Pain Patch Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Pain Patch Market, Regional Market Snapshot
• 8.4. North America Pain Patch Market
  • 8.4.1. U.S. Pain Patch Market
    • 8.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Pain Patch Market
• 8.5. Europe Pain Patch Market Snapshot
  • 8.5.1. U.K. Pain Patch Market
  • 8.5.2. Germany Pain Patch Market
  • 8.5.3. France Pain Patch Market
  • 8.5.4. Spain Pain Patch Market
  • 8.5.5. Italy Pain Patch Market
  • 8.5.6. Rest of Europe Pain Patch Market
• 8.6. Asia-Pacific Pain Patch Market Snapshot
  • 8.6.1. China Pain Patch Market
  • 8.6.2. India Pain Patch Market
  • 8.6.3. Japan Pain Patch Market
  • 8.6.4. Australia Pain Patch Market
  • 8.6.5. South Korea Pain Patch Market
  • 8.6.6. Rest of Asia Pacific Pain Patch Market
• 8.7. Latin America Pain Patch Market Snapshot
  • 8.7.1. Brazil Pain Patch Market
  • 8.7.2. Mexico Pain Patch Market
• 8.8. Middle East & Africa Pain Patch Market
  • 8.8.1. Saudi Arabia Pain Patch Market
  • 8.8.2. South Africa Pain Patch Market
  • 8.8.3. Rest of Middle East & Africa Pain Patch Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. NEXGEL Advanced Hydrogel Solutions
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Viatris Inc.
  • 9.3.3. Johnson and Johnson
  • 9.3.4. Teva Pharmaceutical Industries Ltd.
  • 9.3.5. Sorrento Therapeutics Inc.
  • 9.3.6. Hisamitsu Pharmaceutical Co.,Inc.
  • 9.3.7. Endo International plc.
  • 9.3.8. Purdue Pharma L.P.
  • 9.3.9. Amneal Pharmaceuticals LLC
  • 9.3.10. Grunenthal

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption